Market Cap 10.37M
Revenue (ttm) 30,000.00
Net Income (ttm) -13.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -44,733.33%
Debt to Equity Ratio -0.04
Volume 70,100
Avg Vol 155,500
Day's Range N/A - N/A
Shares Out 1.65M
Stochastic %K 0%
Beta 2.15
Analysts Strong Sell
Price Target $16.50

Company Profile

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in South Korea. Its lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase 3 clinical trial, for the treatment of glioblastoma, isocitrate dehydrogenase-mutant glioma, diffuse intrinsic pontine glioma, atypical teratoid/rhabdoid tumor, brain metast...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 2 9472 4101
Address:
Three International Towers, Level 24 300 Barangaroo Avenue, Sydney, Australia
Dollar_1
Dollar_1 Nov. 14 at 8:48 PM
$KZIA did friend died or what ? Y this fuck is going down again ?
1 · Reply
elmono
elmono Nov. 14 at 6:17 PM
$XBI new all time low for $KZIA …another shit stain in microcap zombie bios’s….short at will 🤷‍♂️😂…value destruction machine
0 · Reply
FerBull
FerBull Nov. 14 at 4:21 PM
$KZIA why is it selling of today on no news?
1 · Reply
FerBull
FerBull Nov. 12 at 10:54 PM
$KZIA I can see less than 1000 shares on the ask between USD 7 and 10, next is at USD 20 on the level 2. This is so much asking for a short squeeze.
1 · Reply
StantheMan32
StantheMan32 Nov. 12 at 5:48 PM
$KZIA https://hotcopper.com.au/threads/86-reduction-in-overall-cancer-tumor-burden.8806453/page-20?post_id=81605446 Just in from a guy called Needle(lol) in Aussie land
0 · Reply
UnwindY
UnwindY Nov. 11 at 8:42 PM
$KZIA NXXT trading like no one’s watching. But Geode +2,274%, Vanguard +131%, UBS +314%, BlackRock entered. 3M shares locked. Earnings any day now. This isn’t “if it runs” — it’s “when.” 🧠
0 · Reply
BULLNATION_
BULLNATION_ Nov. 11 at 7:39 PM
$KZIA SHE IS SO GOOD!!! $22 to $30 on premarket with 2M volume 🔥🚀👀
0 · Reply
BULLNATION_
BULLNATION_ Nov. 11 at 7:35 PM
$KZIA Ph2 & Ph3 readouts in Q4 2025. NOT SELLING ANYTIME UNTIL HUGE READOUT NEWS!
0 · Reply
isabellahart99
isabellahart99 Nov. 11 at 7:34 PM
$KZIA You don’t get 48 institutions in a $1.74 small cap by accident. Vanguard, UBS, Geode went heavy. ER window open now. NXXT ready to unlock full value 🔓📈
0 · Reply
StantheMan32
StantheMan32 Nov. 11 at 7:11 PM
$KZIA November 24th
1 · Reply
Latest News on KZIA
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER

Sep 12, 2024, 7:30 AM EDT - 1 year ago

KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER


KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS

Jan 18, 2024, 7:30 AM EST - 1 year ago

KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS


KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION

Nov 20, 2023, 4:30 PM EST - 2 years ago

KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION


Kazia announces voluntary delisting from ASX

Oct 11, 2023, 7:01 AM EDT - 2 years ago

Kazia announces voluntary delisting from ASX


KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS

Jan 16, 2023, 7:01 AM EST - 3 years ago

KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS


Dollar_1
Dollar_1 Nov. 14 at 8:48 PM
$KZIA did friend died or what ? Y this fuck is going down again ?
1 · Reply
elmono
elmono Nov. 14 at 6:17 PM
$XBI new all time low for $KZIA …another shit stain in microcap zombie bios’s….short at will 🤷‍♂️😂…value destruction machine
0 · Reply
FerBull
FerBull Nov. 14 at 4:21 PM
$KZIA why is it selling of today on no news?
1 · Reply
FerBull
FerBull Nov. 12 at 10:54 PM
$KZIA I can see less than 1000 shares on the ask between USD 7 and 10, next is at USD 20 on the level 2. This is so much asking for a short squeeze.
1 · Reply
StantheMan32
StantheMan32 Nov. 12 at 5:48 PM
$KZIA https://hotcopper.com.au/threads/86-reduction-in-overall-cancer-tumor-burden.8806453/page-20?post_id=81605446 Just in from a guy called Needle(lol) in Aussie land
0 · Reply
UnwindY
UnwindY Nov. 11 at 8:42 PM
$KZIA NXXT trading like no one’s watching. But Geode +2,274%, Vanguard +131%, UBS +314%, BlackRock entered. 3M shares locked. Earnings any day now. This isn’t “if it runs” — it’s “when.” 🧠
0 · Reply
BULLNATION_
BULLNATION_ Nov. 11 at 7:39 PM
$KZIA SHE IS SO GOOD!!! $22 to $30 on premarket with 2M volume 🔥🚀👀
0 · Reply
BULLNATION_
BULLNATION_ Nov. 11 at 7:35 PM
$KZIA Ph2 & Ph3 readouts in Q4 2025. NOT SELLING ANYTIME UNTIL HUGE READOUT NEWS!
0 · Reply
isabellahart99
isabellahart99 Nov. 11 at 7:34 PM
$KZIA You don’t get 48 institutions in a $1.74 small cap by accident. Vanguard, UBS, Geode went heavy. ER window open now. NXXT ready to unlock full value 🔓📈
0 · Reply
StantheMan32
StantheMan32 Nov. 11 at 7:11 PM
$KZIA November 24th
1 · Reply
BULLNATION_
BULLNATION_ Nov. 11 at 6:51 PM
$KZIA After 8.06 we have huge gap up to $11. This will trigger the double digits run! Getting some shares before end bell!
0 · Reply
BULLNATION_
BULLNATION_ Nov. 11 at 4:11 PM
$KZIA Rising our PT above Maxim Group to $22 is minimum and with the next massive news we can gap up to $30 with 2M volume premarket. Trust the process! Product is real and great!
0 · Reply
LabMan
LabMan Nov. 11 at 7:32 AM
$KZIA It is a fact, there is no drug in this class, that has the broad profile of paxalisib. ONLY this drug has been designed with all four protein family isoforms - (and mTOR) to inhibit PI3Kα, PI3Kβ, PI3Kδ, and PI3Ky, deregulated signaling cancer pathways. The ability of paxalisib to also work in the brain, establishes this drug, as a premier cancer, metabolic combination cancer drug treatment. The value of the drug is immense. Generally, inhibiting PI3Kα and PI3Kβ directly impedes tumor growth, while targeting PI3Kδ and PI3Kγ mainly enhances tumor immunity by modulating immune cell functions. Paxalisib has already been shown to dynamically enhance the immune response and can make a significant advancement in cancer treatment strategies. What is being established, is unquestionable potential for pAX to become part of the future oncologic regimens to improve cancer treatment, in general.
0 · Reply
BULLNATION_
BULLNATION_ Nov. 10 at 8:39 PM
$KZIA This week is ours bulls! RSI is bull zoned and MACD ready for green momentum! Price is set to go! Load up when you can before 40% to 230% run!
1 · Reply
BULLNATION_
BULLNATION_ Nov. 10 at 2:39 PM
$KZIA FDA Approving Type C meeting is huge! As we can sit down and talk about great data results company has. Think about it, if company was not confident on their result, why would they want to be considered to join FrontRunner FDA program? FrontRunner is a program for companies to achieve great results and want to join a fast-track on Phase 3. This helps company to not come up with full funds ($30M to $50 ) and fund their own Phase 3. Stock is technically on bull territory to test $11 and $22 (Maxim Group PT $20)
0 · Reply
BULLNATION_
BULLNATION_ Nov. 10 at 1:59 PM
$NAOV $WLDS $KZIA All markets are being red lately, just enjoy the discounts people! Markets have shown us with dips and historic runs. Load up on companies that are fundamentally great, have real product, real numbers, and promising data/development.
0 · Reply
StantheMan32
StantheMan32 Nov. 10 at 1:49 AM
$KZIA What happened to the 61 year old lady? Did they get a partial response? Where does the stock go with a meaningful ORR?
0 · Reply
StantheMan32
StantheMan32 Nov. 10 at 1:47 AM
$KZIA Time to show us the breast cancer data. What is Friend waiting for? Print it
0 · Reply
futureexmillionare
futureexmillionare Nov. 10 at 1:28 AM
$KZIA did anyone read the annual report ? any thoughts ? we are still far away .. still undervalued.. with constant short on funds.. diluting shares… good news but our SP not showing any love. The meeting feels like deja vu from last year. Now that government will be open FDA will be back at work. Also we paid 1.39 mil.
1 · Reply
StantheMan32
StantheMan32 Nov. 9 at 3:48 PM
$KZIA Approx 200k new shares added from "small" ATM tap to fund the recent PD-L1 degrader program puts share cound at approx 1.9 mill outstanding.
1 · Reply
futureexmillionare
futureexmillionare Nov. 9 at 12:38 AM
1 · Reply
StantheMan32
StantheMan32 Nov. 8 at 3:41 AM
$KZIA On July 31, 2025, we entered into the Securities Purchase Agreements with Alumni Capital LP, Pointillist Global Macro Series of Pointillist Partners, LLC, Daniel Herr and Lauren Rimoin Living Trust and MK Plumeria, LLC in connection with a private placement, pursuant to which we issued and sold (i) 14,204,500 ordinary shares at a purchase price of $0.0176 per share, and (ii) pre-funded Warrants to purchase up to 204,547 ADSs, each ADS representing five hundred ordinary shares, at a purchase price of $8.7999 per pre-funded Warrant. Each pre-funded Warrant is exercisable for one ADS at an exercise price of $0.0001 per ADS underlying the pre-funded Warrant, is immediately exercisable, and will expire when exercised in full.
1 · Reply